|
DBT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.05231403988182E-14 |
| Normal-vs-Stage2 |
1.535030E-03 |
| Normal-vs-Stage3 |
2.77555756156289E-15 |
| Normal-vs-Stage4 |
1.99840144432528E-15 |
| Stage1-vs-Stage2 |
2.405800E-02 |
| Stage1-vs-Stage3 |
2.040200E-02 |
| Stage1-vs-Stage4 |
6.47209999999898E-05 |
| Stage2-vs-Stage3 |
7.831600E-04 |
| Stage2-vs-Stage4 |
1.91606999999649E-05 |
| Stage3-vs-Stage4 |
9.487600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.25740000000985E-06 |
| Normal-vs-Asian |
1.26249999343742E-09 |
| Caucasian-vs-AfricanAmerican |
7.838400E-01 |
| Caucasian-vs-Asian |
9.943800E-01 |
| AfricanAmerican-vs-Asian |
8.124200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24555921132696E-12 |
| Normal-vs-Female |
1.62581059726108E-12 |
| Male-vs-Female |
5.280600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.27295959831508E-12 |
| Normal-vs-Age(41-60Yrs) |
3.24185123190546E-14 |
| Normal-vs-Age(61-80Yrs) |
6.35770325274621E-11 |
| Normal-vs-Age(81-100Yrs) |
4.183900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.468000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.730600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.439800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.252600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.634200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.987800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.951400E-04 |
| Classical-VS-Follicular |
1.03510000004636E-06 |
| Classical-VS-Other |
7.034400E-01 |
| Classical-VS-Normal |
8.40572056404199E-12 |
| Tall-VS-Follicular |
1.65420011022377E-10 |
| Tall-VS-Other |
2.258000E-01 |
| Tall-VS-Normal |
2.1094237467878E-15 |
| Follicular-VS-Other |
6.847500E-02 |
| Follicular-VS-Normal |
2.335100E-03 |
| Other-VS-Normal |
8.952600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.26149995899527E-10 |
| Normal-vs-N1 |
1.62614366416847E-12 |
| N0-vs-N1 |
2.9110999999471E-06 |
|
|
